德展健康
(000813)
| 流通市值:58.08亿 | | | 总市值:58.09亿 |
| 流通股本:20.97亿 | | | 总股本:20.97亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 229,912,038.77 | 142,633,396.76 | 88,623,591.58 | 396,809,685.19 |
| 营业总成本 | 314,380,971.14 | 195,413,055.78 | 120,004,752.18 | 557,810,924.68 |
| 其他经营收益 | | | | |
| 营业利润 | -115,477,566.14 | -67,209,178.91 | -41,146,462.68 | -419,334,479.88 |
| 利润总额 | -117,191,365.32 | -67,602,267.09 | -41,062,740.36 | -420,422,134.55 |
| 净利润 | -128,575,519.32 | -75,307,710.7 | -43,167,923.15 | -421,925,827.96 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | -60,038,939.79 |
| 综合收益总额 | -128,575,519.32 | -75,307,710.7 | -43,167,923.15 | -481,964,767.75 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,503,711,848.51 | 2,121,211,916.97 | 2,171,848,443.41 | 2,568,209,713.74 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,239,358,294.48 | 2,648,329,635.22 | 2,629,250,718.35 | 2,303,799,890.56 |
| 资产总计 | 4,743,070,142.99 | 4,769,541,552.19 | 4,801,099,161.76 | 4,872,009,604.3 |
| 流动负债: | | | | |
| 流动负债合计 | 162,771,341.56 | 133,448,970.4 | 130,103,193.26 | 155,799,089.35 |
| 非流动负债: | | | | |
| 非流动负债合计 | 135,922,966.17 | 138,591,021.85 | 141,542,060.09 | 143,700,597.62 |
| 负债合计 | 298,694,307.73 | 272,039,992.25 | 271,645,253.35 | 299,499,686.97 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,532,581,168.9 | 4,577,726,401.4 | 4,601,314,589.03 | 4,635,625,619.48 |
| 股东权益合计 | 4,444,375,835.26 | 4,497,501,559.94 | 4,529,453,908.41 | 4,572,509,917.33 |
| 负债和股东权益合计 | 4,743,070,142.99 | 4,769,541,552.19 | 4,801,099,161.76 | 4,872,009,604.3 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 292,886,620.66 | 170,096,685.38 | 119,846,853.29 | 476,284,499.92 |
| 经营活动现金流出小计 | 319,000,697.8 | 222,390,579.16 | 103,760,383.8 | 471,562,016.8 |
| 经营活动产生的现金流量净额 | -26,114,077.14 | -52,293,893.78 | 16,086,469.49 | 4,722,483.12 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 7,046,582.48 | 6,393,175 | 3,303,665 | 10,613,088.85 |
| 投资活动现金流出小计 | 1,046,784,186.23 | 415,439,130.64 | 380,838,187.75 | 695,988,546.05 |
| 投资活动产生的现金流量净额 | -1,039,737,603.75 | -409,045,955.64 | -377,534,522.75 | -685,375,457.2 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 0 | 0 | 0 | 118,800,000 |
| 筹资活动现金流出小计 | 8,113,182.59 | 4,727,511.34 | 2,311,295.46 | 139,596,527.89 |
| 筹资活动产生的现金流量净额 | -8,113,182.59 | -4,727,511.34 | -2,311,295.46 | -20,796,527.89 |
| 汇率变动对现金及现金等价物的影响 | 0 | 0 | 0 | 70.93 |
| 现金及现金等价物净增加额 | -1,073,964,863.48 | -466,067,360.76 | -363,759,348.72 | -701,449,431.04 |
| 期末现金及现金等价物余额 | 682,164,247.61 | 1,290,061,750.33 | 1,392,369,762.37 | 1,756,129,111.09 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -466,067,360.76 | - | -701,449,431.04 |